PARK2 as a susceptibility factor for nontuberculous mycobacterial pulmonary disease
Open Access
- 14 August 2024
- journal article
- research article
- Published by Springer Nature in Respiratory Research
- Vol. 25 (1) , 1-10
Abstract
Background: The genetic signatures associated with the susceptibility to nontuberculous mycobacterial pulmonary disease (NTM-PD) are still unknown. In this study, we performed RNA sequencing to explore gene expression profiles and represent characteristic factor in NTM-PD. Methods: Peripheral blood samples were collected from patients with NTM-PD and healthy individuals (controls). Differentially expressed genes (DEGs) were identified by RNA sequencing and subjected to functional enrichment and immune cell deconvolution analyses. Results: We enrolled 48 participants, including 26 patients with NTM-PD (median age, 58.0 years; 84.6% female), and 22 healthy controls (median age, 58.5 years; 90.9% female). We identified 21 upregulated and 44 downregulated DEGs in the NTM-PD group compared to those in the control group. NTM infection did not have a significant impact on gene expression in the NTM-PD group compared to the control group, and there were no differences in the proportion of immune cells. However, through gene ontology (GO), gene set enrichment analysis (GSEA), and protein-protein interaction (PPI) analysis, we discovered that PARK2 is a key factor associated with NTM-PD. The PARK2 gene, which is linked to the ubiquitination pathway, was downregulated in the NTM-PD group (fold change, − 1.314, P = 0.047). The expression levels of PARK2 remained unaltered after favorable treatment outcomes, suggesting that the gene is associated with host susceptibility rather than with the outcomes of infection or inflammation. The area under the receiver operating characteristic curve for the PARK2 gene diagnosing NTM-PD was 0.813 (95% confidence interval, 0.694–0.932). Conclusion: We identified the genetic signatures associated with NTM-PD in a cohort of Korean patients. The PARK2 gene presents as a potential susceptibility factor in NTM-PD .Keywords
Funding Information
- National Research Foundation of Korea (2018R1A5A2025079)
This publication has 53 references indexed in Scilit:
- Global Epidemiology of Nontuberculous Mycobacterial Pulmonary DiseaseClinics in Chest Medicine, 2023
- Global trends of pulmonary infections with nontuberculous mycobacteria: a systematic reviewInternational Journal of Infectious Diseases, 2022
- Blood transcriptional biomarkers for active pulmonary tuberculosis in a high-burden setting: a prospective, observational, diagnostic accuracy studyThe Lancet Respiratory Medicine, 2020
- Comprehensive diagnostics of acute myeloid leukemia by whole transcriptome RNA sequencingLeukemia, 2020
- Serum Anti-interferon-γ Autoantibody Titer as a Potential Biomarker of Disseminated Non-tuberculous Mycobacterial InfectionJournal of Clinical Immunology, 2020
- Parkinson’s Disease-Related Proteins PINK1 and Parkin Repress Mitochondrial Antigen PresentationCell, 2016
- Robust enumeration of cell subsets from tissue expression profilesNature Methods, 2015
- Bacteria–autophagy interplay: a battle for survivalNature Reviews Microbiology, 2014
- The ubiquitin ligase parkin mediates resistance to intracellular pathogensNature, 2013
- Susceptibility to leprosy is associated with PARK2 and PACRGNature, 2004